Abstract
Reversible protein phosphorylation is an essential cellular regulatory mechanism. Many proteins integrate and are modulated by multiple phosphorylation events derived from complex signaling cues. Simultaneous detection and quantification of temporal changes in all of a protein's phosphorylation sites could provide not only an immediate assessment of a known biochemical activity but also important insights into molecular signaling mechanisms. Here we show the use of stable isotope-based quantitative MS to globally monitor the kinetics of complex, ordered phosphorylation events on protein players in the canonical mitogen-activated protein kinase signaling pathway. In excellent agreement with activity assays and phosphospecific immunoblotting with the same samples, we quantified epidermal growth factor-induced changes in nine phosphorylation sites in the extracellular signal-regulated kinase (ERK)/p90 ribosomal S6 kinase-signaling cassette. Additionally, we monitored 14 previously uncharacterized and six known phosphorylation events after phorbol ester stimulation in the ERK/p90 ribosomal S6 kinase-signaling targets, the tuberous sclerosis complex (TSC) tumor suppressors TSC1 and TSC2. By using quantitative phosphorylation profiling in conjunction with pharmacological kinase inhibitors we uncovered a ERK-independent, protein kinase C-dependent pathway to TSC2 phosphorylation. These results establish quantitative phosphorylation profiling as a means to simultaneously identify, quantify, and delineate the kinetic changes of ordered phosphorylation events on a given protein and defines parameters for the rapid discovery of important in vivo phosphoregulatory mechanisms.
MeSH Terms
Binding Sites/drug effects
Cell Line
Epidermal Growth Factor/pharmacology
Humans
MAP Kinase Signaling System
Mass Spectrometry/methods
Phorbol Esters/pharmacology
Phosphorus Isotopes
Phosphorylation
Protein Kinase C/metabolism
Repressor Proteins
Ribosomal Protein S6 Kinases, 90-kDa/metabolism
Tuberous Sclerosis
Tuberous Sclerosis Complex 1 Protein
Tuberous Sclerosis Complex 2 Protein
Tumor Suppressor Proteins/metabolism
Chemicals
Phorbol Esters
Phosphorus Isotopes
Repressor Proteins
TSC1 protein, human
TSC2 protein, human
Tuberous Sclerosis Complex 1 Protein
Tuberous Sclerosis Complex 2 Protein
Tumor Suppressor Proteins
Epidermal Growth Factor
Ribosomal Protein S6 Kinases, 90-kDa
Protein Kinase C
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ballif Bryan A
Department of Cell Biology and Taplin Biological Mass Spectrometry Facility, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.
Roux Philippe P
Gerber Scott A
MacKeigan Jeffrey P
Blenis John
Gygi Steven P
References (15)
15 references, click to expand
-
Site-specific mass tagging with stable isotopes in proteins for accurate and efficient protein identification.
Anal Chem. 2000 Mar 15;72(6):1134-43
PMID: 10740850
-
Phosphoproteomic analysis of the developing mouse brain.
Mol Cell Proteomics. 2004 Nov;3(11):1093-101
PMID: 15345747
-
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.
Mol Cell Proteomics. 2002 May;1(5):376-86
PMID: 12118079
-
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6
PMID: 12271141
-
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling.
Biochem Soc Trans. 2003 Jun;31(Pt 3):573-8
PMID: 12773158
-
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS.
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6940-5
PMID: 12771378
-
Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Mol Cell Biol. 2003 Jul;23(14):4796-804
PMID: 12832467
-
A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture.
Anal Chem. 2003 Nov 15;75(22):6043-9
PMID: 14615979
-
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.
Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44
PMID: 15187187
-
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
Genes Dev. 2004 Jul 1;18(13):1533-8
PMID: 15231735
-
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.
Nat Biotechnol. 2004 Sep;22(9):1139-45
PMID: 15314609
-
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94
PMID: 15342917
-
Identification of Xenopus S6 protein kinase homologs (pp90rsk) in somatic cells: phosphorylation and activation during initiation of cell proliferation.
Mol Cell Biol. 1990 Jun;10(6):3204-15
PMID: 2342472
-
Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK.
Curr Biol. 1999 Jul 29-Aug 12;9(15):810-20
PMID: 10469565
-
Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-l-phenylalanyl chloromethyl ketone.
J Biol Chem. 2001 Apr 13;276(15):12466-75
PMID: 11278584